Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates

Roundhill, E.A. orcid.org/0000-0002-0508-3648, Pantziarka, P., Liddle, D.E. et al. (3 more authors) (2023) Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates. Cancers, 15 (3). 769. ISSN 2072-6694

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Keywords: Ewing sarcoma; stemness; pluripotency; CD133; multidrug resistance; ABCG1; POU5F1/CT-4; drug repurposing
Dates:
  • Published: 1 February 2023
  • Published (online): 26 January 2023
  • Accepted: 17 January 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Molecular Medicine
Depositing User: Symplectic Publications
Date Deposited: 18 Feb 2025 12:04
Last Modified: 18 Feb 2025 12:04
Status: Published
Publisher: MDPI
Identification Number: 10.3390/cancers15030769
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics